2023-03-012024-02-292024-02-29false13888625KKRC HEALTHCARE LTD2024-11-2886900iso4217:GBPxbrli:pure138886252023-03-01138886252024-02-29138886252023-03-012024-02-29138886252022-02-02138886252023-02-28138886252022-02-022023-02-2813888625bus:SmallEntities2023-03-012024-02-2913888625bus:AuditExempt-NoAccountantsReport2023-03-012024-02-2913888625bus:FullAccounts2023-03-012024-02-2913888625bus:PrivateLimitedCompanyLtd2023-03-012024-02-2913888625core:WithinOneYear2024-02-2913888625core:AfterOneYear2024-02-2913888625core:WithinOneYear2023-02-2813888625core:AfterOneYear2023-02-2813888625core:ShareCapital2024-02-2913888625core:SharePremium2024-02-2913888625core:RevaluationReserve2024-02-2913888625core:OtherReservesSubtotal2024-02-2913888625core:RetainedEarningsAccumulatedLosses2024-02-2913888625core:ShareCapital2023-02-2813888625core:SharePremium2023-02-2813888625core:RevaluationReserve2023-02-2813888625core:OtherReservesSubtotal2023-02-2813888625core:RetainedEarningsAccumulatedLosses2023-02-2813888625core:LandBuildings2024-02-2913888625core:PlantMachinery2024-02-2913888625core:Vehicles2024-02-2913888625core:FurnitureFittings2024-02-2913888625core:OfficeEquipment2024-02-2913888625core:NetGoodwill2024-02-2913888625core:IntangibleAssetsOtherThanGoodwill2024-02-2913888625core:ListedExchangeTraded2024-02-2913888625core:UnlistedNon-exchangeTraded2024-02-2913888625core:LandBuildings2023-02-2813888625core:PlantMachinery2023-02-2813888625core:Vehicles2023-02-2813888625core:FurnitureFittings2023-02-2813888625core:OfficeEquipment2023-02-2813888625core:NetGoodwill2023-02-2813888625core:IntangibleAssetsOtherThanGoodwill2023-02-2813888625core:ListedExchangeTraded2023-02-2813888625core:UnlistedNon-exchangeTraded2023-02-2813888625core:LandBuildings2023-03-012024-02-2913888625core:PlantMachinery2023-03-012024-02-2913888625core:Vehicles2023-03-012024-02-2913888625core:FurnitureFittings2023-03-012024-02-2913888625core:OfficeEquipment2023-03-012024-02-2913888625core:NetGoodwill2023-03-012024-02-2913888625core:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2913888625core:ListedExchangeTraded2023-03-012024-02-2913888625core:UnlistedNon-exchangeTraded2023-03-012024-02-2913888625core:MoreThanFiveYears2023-03-012024-02-2913888625core:Non-currentFinancialInstruments2024-02-2913888625core:Non-currentFinancialInstruments2023-02-2813888625dpl:CostSales2023-03-012024-02-2913888625dpl:DistributionCosts2023-03-012024-02-2913888625core:LandBuildings2023-03-012024-02-2913888625core:PlantMachinery2023-03-012024-02-2913888625core:Vehicles2023-03-012024-02-2913888625core:FurnitureFittings2023-03-012024-02-2913888625core:OfficeEquipment2023-03-012024-02-2913888625dpl:AdministrativeExpenses2023-03-012024-02-2913888625core:NetGoodwill2023-03-012024-02-2913888625core:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2913888625dpl:GroupUndertakings2023-03-012024-02-2913888625dpl:ParticipatingInterests2023-03-012024-02-2913888625dpl:GroupUndertakingscore:ListedExchangeTraded2023-03-012024-02-2913888625core:ListedExchangeTraded2023-03-012024-02-2913888625dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-03-012024-02-2913888625core:UnlistedNon-exchangeTraded2023-03-012024-02-2913888625dpl:CostSales2022-02-022023-02-2813888625dpl:DistributionCosts2022-02-022023-02-2813888625core:LandBuildings2022-02-022023-02-2813888625core:PlantMachinery2022-02-022023-02-2813888625core:Vehicles2022-02-022023-02-2813888625core:FurnitureFittings2022-02-022023-02-2813888625core:OfficeEquipment2022-02-022023-02-2813888625dpl:AdministrativeExpenses2022-02-022023-02-2813888625core:NetGoodwill2022-02-022023-02-2813888625core:IntangibleAssetsOtherThanGoodwill2022-02-022023-02-2813888625dpl:GroupUndertakings2022-02-022023-02-2813888625dpl:ParticipatingInterests2022-02-022023-02-2813888625dpl:GroupUndertakingscore:ListedExchangeTraded2022-02-022023-02-2813888625core:ListedExchangeTraded2022-02-022023-02-2813888625dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-02-022023-02-2813888625core:UnlistedNon-exchangeTraded2022-02-022023-02-2813888625core:NetGoodwill2024-02-2913888625core:IntangibleAssetsOtherThanGoodwill2024-02-2913888625core:LandBuildings2024-02-2913888625core:PlantMachinery2024-02-2913888625core:Vehicles2024-02-2913888625core:FurnitureFittings2024-02-2913888625core:OfficeEquipment2024-02-2913888625core:AfterOneYear2024-02-2913888625core:WithinOneYear2024-02-2913888625core:ListedExchangeTraded2024-02-2913888625core:UnlistedNon-exchangeTraded2024-02-2913888625core:ShareCapital2024-02-2913888625core:SharePremium2024-02-2913888625core:RevaluationReserve2024-02-2913888625core:OtherReservesSubtotal2024-02-2913888625core:RetainedEarningsAccumulatedLosses2024-02-2913888625core:NetGoodwill2023-02-2813888625core:IntangibleAssetsOtherThanGoodwill2023-02-2813888625core:LandBuildings2023-02-2813888625core:PlantMachinery2023-02-2813888625core:Vehicles2023-02-2813888625core:FurnitureFittings2023-02-2813888625core:OfficeEquipment2023-02-2813888625core:AfterOneYear2023-02-2813888625core:WithinOneYear2023-02-2813888625core:ListedExchangeTraded2023-02-2813888625core:UnlistedNon-exchangeTraded2023-02-2813888625core:ShareCapital2023-02-2813888625core:SharePremium2023-02-2813888625core:RevaluationReserve2023-02-2813888625core:OtherReservesSubtotal2023-02-2813888625core:RetainedEarningsAccumulatedLosses2023-02-2813888625core:NetGoodwill2022-02-0213888625core:IntangibleAssetsOtherThanGoodwill2022-02-0213888625core:LandBuildings2022-02-0213888625core:PlantMachinery2022-02-0213888625core:Vehicles2022-02-0213888625core:FurnitureFittings2022-02-0213888625core:OfficeEquipment2022-02-0213888625core:AfterOneYear2022-02-0213888625core:WithinOneYear2022-02-0213888625core:ListedExchangeTraded2022-02-0213888625core:UnlistedNon-exchangeTraded2022-02-0213888625core:ShareCapital2022-02-0213888625core:SharePremium2022-02-0213888625core:RevaluationReserve2022-02-0213888625core:OtherReservesSubtotal2022-02-0213888625core:RetainedEarningsAccumulatedLosses2022-02-0213888625core:AfterOneYear2023-03-012024-02-2913888625core:WithinOneYear2023-03-012024-02-2913888625core:Non-currentFinancialInstrumentscore:CostValuation2023-03-012024-02-2913888625core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-012024-02-2913888625core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-012024-02-2913888625core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-012024-02-2913888625core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-012024-02-2913888625core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-012024-02-2913888625core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2913888625core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2913888625core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2913888625core:Non-currentFinancialInstrumentscore:CostValuation2024-02-2913888625core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-2913888625core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-2913888625core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-2913888625core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-2913888625core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-2913888625core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-2913888625core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-2913888625core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-2913888625core:Non-currentFinancialInstrumentscore:CostValuation2023-02-2813888625core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-02-2813888625core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-02-2813888625core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-02-2813888625core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-02-2813888625core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-02-2813888625core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-02-2813888625core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-02-2813888625core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-02-2813888625bus:Director12023-03-012024-02-2913888625bus:Director22023-03-012024-02-29

KKRC HEALTHCARE LTD

Registered Number
13888625
(England and Wales)

Unaudited Financial Statements for the Year ended
29 February 2024

KKRC HEALTHCARE LTD
Company Information
for the year from 1 March 2023 to 29 February 2024

Directors

GANESAN, Kamal Raj
KAMAL RAJ, Kirubananthini

Registered Address

35 Gorseyfields
Droylsden
M43 6DZ

Registered Number

13888625 (England and Wales)
KKRC HEALTHCARE LTD
Balance Sheet as at
29 February 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets3228305
228305
Current assets
Debtors435,281861
Cash at bank and on hand32932,912
35,61033,773
Creditors amounts falling due within one year5(16,440)(10,996)
Net current assets (liabilities)19,17022,777
Total assets less current liabilities19,39823,082
Net assets19,39823,082
Capital and reserves
Called up share capital1002
Profit and loss account19,29823,080
Shareholders' funds19,39823,082
The financial statements were approved and authorised for issue by the Board of Directors on 28 November 2024, and are signed on its behalf by:
KAMAL RAJ, Kirubananthini
Director
Registered Company No. 13888625
KKRC HEALTHCARE LTD
Notes to the Financial Statements
for the year ended 29 February 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Office Equipment25
Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments. Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. Basic financial assets Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised. Classification of financial liabilities Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Basic financial liabilities Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

20242023
Average number of employees during the year22
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 March 23311311
At 29 February 24311311
Depreciation and impairment
At 01 March 2366
Charge for year7777
At 29 February 248383
Net book value
At 29 February 24228228
At 28 February 23305305
4.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables4,708681
Other debtors30,573-
Prepayments and accrued income-180
Total35,281861
5.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables-1
Taxation and social security14,23610,394
Other creditors403172
Accrued liabilities and deferred income1,801429
Total16,44010,996
6.Related party transactions
Included in other debtors falling due within one year are due from companies connected to the director GM Arokiya Ltd £30,573 (2023: Nil); Included in other creditors falling due within one year are amount to the director £403 (2023: £172).